Grant: Master's Award: Canada Graduate Scholarships
McGill University
$27,000.00
Demystifying Sildenafil’s Impact on Neuronal Cell Death Prevention in Neonatal Hypoxic-Ischemic Encephalopathy
EF 2024-25
Résumé
The newborn period is a fragile time, where complications can have lasting effects on a child’s development. One of the most serious complications is hypoxic-ischemic brain injury, which occurs when a baby’s brain does get enough oxygen or blood. This lack of oxygen or blood triggers multiple harmful processes in the brain that can lead to the loss of brain cells (neurons). As a result, affected infants often face long-term challenges, such as learning difficulties, physical disabilities, and in severe cases, even death. Currently, the only standard treatment for this condition is cooling the baby’s body (hypothermia) to slow down brain damage. However, while this treatment can help some babies, many still experience lasting neurological problems despite therapy.
Interestingly, sildenafil (commonly known as Viagra®) has shown promising benefits in adults recovering from strokes by supporting brain healing and improving cognitive function. Research from our lab has found that sildenafil may have similar positive effects on babies with hypoxic-ischemic brain injury. More specifically, we saw that treatment with sildenafil helped protect brain cells from dying and supported the growth of new brain cells in infants with this disease. Unfortunately, the exact processes that lead to cell death in this condition are not fully understood, hindering the creation of improved treatment options.
This project aims to explore how different brain cell death pathways are activated by hypoxic-ischemic brain injury and how treatments like hypothermia and sildenafil can affect these processes. By better understanding the way these treatments work, we hope to develop more effective therapies to protect and heal the brains of babies affected by this serious condition.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530096
Name
Okaro Ivana
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Demystifying Sildenafil’s Impact on Neuronal Cell Death Prevention in Neonatal Hypoxic-Ischemic Encephalopathy
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Death; Hypoxia-Ischemia; Neurodevelopment; Newborn Disease; Sildenafil
Abstract
The newborn period is a fragile time, where complications can have lasting effects on a child’s development. One of the most serious complications is hypoxic-ischemic brain injury, which occurs when a baby’s brain does get enough oxygen or blood. This lack of oxygen or blood triggers multiple harmful processes in the brain that can lead to the loss of brain cells (neurons). As a result, affected infants often face long-term challenges, such as learning difficulties, physical disabilities, and in severe cases, even death. Currently, the only standard treatment for this condition is cooling the baby’s body (hypothermia) to slow down brain damage. However, while this treatment can help some babies, many still experience lasting neurological problems despite therapy.
Interestingly, sildenafil (commonly known as Viagra®) has shown promising benefits in adults recovering from strokes by supporting brain healing and improving cognitive function. Research from our lab has found that sildenafil may have similar positive effects on babies with hypoxic-ischemic brain injury. More specifically, we saw that treatment with sildenafil helped protect brain cells from dying and supported the growth of new brain cells in infants with this disease. Unfortunately, the exact processes that lead to cell death in this condition are not fully understood, hindering the creation of improved treatment options.
This project aims to explore how different brain cell death pathways are activated by hypoxic-ischemic brain injury and how treatments like hypothermia and sildenafil can affect these processes. By better understanding the way these treatments work, we hope to develop more effective therapies to protect and heal the brains of babies affected by this serious condition.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Okaro, Ivana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~